These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12973686)

  • 1. Co-expression of trypsin and tumour-associated trypsin inhibitor (TATI) in colorectal adenocarcinomas.
    Solakidi S; Tiniakos DG; Petraki K; Stathopoulos GP; Markaki I; Androulakis G; Sekeris CE
    Histol Histopathol; 2003 Oct; 18(4):1181-8. PubMed ID: 12973686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancer.
    Koskensalo S; Hagström J; Louhimo J; Stenman UH; Haglund C
    Oncology; 2012; 82(4):234-41. PubMed ID: 22508321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients.
    Lukkonen A; Lintula S; von Boguslawski K; Carpén O; Ljungberg B; Landberg G; Stenman UH
    Int J Cancer; 1999 Nov; 83(4):486-90. PubMed ID: 10508484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer.
    Wiksten JP; Lundin J; Nordling S; Kokkola A; Stenman UH; Haglund C
    Histopathology; 2005 Apr; 46(4):380-8. PubMed ID: 15810949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancer.
    Hotakainen K; Bjartell A; Sankila A; Järvinen R; Paju A; Rintala E; Haglund C; Stenman UH
    Int J Oncol; 2006 Jan; 28(1):95-101. PubMed ID: 16327984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
    Paju A; Vartiainen J; Haglund C; Itkonen O; von Boguslawski K; Leminen A; Wahlström T; Stenman UH
    Clin Cancer Res; 2004 Jul; 10(14):4761-8. PubMed ID: 15269150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients.
    Gaber A; Stene C; Hotakainen K; Nodin B; Palmquist I; Bjartell A; Stenman UH; Jeppsson B; Johnson LB; Jirström K
    Radiat Oncol; 2011 Aug; 6():100. PubMed ID: 21864386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer.
    Saleh S; Lam AK; Ho YH
    Pathology; 2008 Jan; 40(1):25-30. PubMed ID: 18038311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242.
    Pasanen P; Eskelinen M; Kulju A; Penttilä I; Janatuinen E; Alhava E
    Scand J Clin Lab Invest; 1995 Apr; 55(2):119-24. PubMed ID: 7667604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
    Paju A; Hotakainen K; Cao Y; Laurila T; Gadaleanu V; Hemminki A; Stenman UH; Bjartell A
    Eur Urol; 2007 Dec; 52(6):1670-9. PubMed ID: 17306443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
    Gaber A; Nodin B; Hotakainen K; Nilsson E; Stenman UH; Bjartell A; Birgisson H; Jirström K
    BMC Cancer; 2010 Sep; 10():498. PubMed ID: 20849596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.
    Lee YC; Pan HW; Peng SY; Lai PL; Kuo WS; Ou YH; Hsu HC
    Eur J Cancer; 2007 Mar; 43(4):736-44. PubMed ID: 17267202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
    Gaber A; Johansson M; Stenman UH; Hotakainen K; Pontén F; Glimelius B; Bjartell A; Jirström K; Birgisson H
    Br J Cancer; 2009 May; 100(10):1540-8. PubMed ID: 19384300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-associated trypsin inhibitor, carcinoembryonic antigen and acute-phase reactant proteins CRP and alpha1-antitrypsin in patients with gastrointestinal malignancies.
    Solakidi S; Dessypris A; Stathopoulos GP; Androulakis G; Sekeris CE
    Clin Biochem; 2004 Jan; 37(1):56-60. PubMed ID: 14675563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-associated trypsin inhibitor and tumour-associated trypsin.
    Stenman UH
    Scand J Clin Lab Invest Suppl; 1990; 201():93-101. PubMed ID: 2244188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human trypsinogen in colorectal cancer.
    Williams SJ; Gotley DC; Antalis TM
    Int J Cancer; 2001 Jul; 93(1):67-73. PubMed ID: 11391623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypsinogen-1, -2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas.
    Hedström J; Haglund C; Leinonen J; Nordling S; Stenman UH
    Scand J Clin Lab Invest; 2001 Apr; 61(2):111-8. PubMed ID: 11347977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue.
    Yu LL; Yu HG; Yu JP; Luo HS
    Eksp Onkol; 2004 Mar; 26(1):40-7. PubMed ID: 15112579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
    Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
    Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.